Assist Prof Dr. Duygu KIRKIK | Immunogenetics | Young Scientist Award

Assist Prof at Immunogenetics, University of Health Sciences, Turkey

Duygu Kirkik is an Assistant Professor holding Ph.D., M.Sc., and B.Sc. degrees. She is an accomplished academic with expertise in [her field/areas of interest]. Her research focuses on [research interests], and she has contributed to several publications in reputable journals. Dr. Kirkik is dedicated to academic excellence and is actively involved in [any relevant activities or projects].

Professional Profiles:

Education:

Assistant Professor Dr. Duygu Kirkik is an accomplished academic with a strong background in medical genetics. She obtained her Ph.D. in Medical Genetics from the University of Health Sciences, Turkey, where her research focused on the characterization of the microbiota and the role of inflammasome components in Crohn’s patients. Dr. Kirkik also holds a Master’s degree in Medical Genetics from Fatih University, during which she conducted research on the Crimean-Congo Hemorrhagic Fever Virus. Her diverse educational background includes a Bachelor’s degree in Biology from Fatih University. Dr. Kirkik’s passion for research and teaching is evident in her current roles as a Clinical Researcher at Rigicon, Inc and as a Lecturer/Assistant Professor at Arel University in Turkey. Her dedication to the field of medical genetics and her commitment to advancing knowledge in the field make her a valuable asset to the academic community.

Work Experience:

Dr. Duygu Kirkik has a diverse professional background in research and academia. She currently serves as a Clinical Researcher at Rigicon, Inc in Ronkonkoma, NY, where she is involved in cutting-edge research. Dr. Kirkik also holds positions at Arel University in Turkey, serving as a Lecturer/Assistant Professor in both the Department of Medical Biology and Genetics and the Department of Biomedical Engineering since October 2022. Prior to these roles, she gained valuable experience as a Research Assistant at the University of Health Sciences in Istanbul, Turkey, from February 2017 to February 2023. Dr. Kirkik’s academic journey began at Oxford University, where she worked as a Research Assistant at the Weatherall Institute of Molecular Medicine from June 2013 to September 2014. Her diverse experiences have shaped her into a well-rounded professional with a strong commitment to research and education.

Research Interest:

Dr. Duygu Kirkik has a broad range of research interests spanning various fields including infection, immunology, autoimmunity, microbiota, bioinformatics, urology, penile prosthesis, and incontinence. Her research focuses on understanding the complex interactions between the immune system and infectious agents, as well as the role of microbiota in health and disease. Dr. Kirkik is also interested in the development of bioinformatics tools to analyze large datasets in these areas. Her work in urology includes research on penile prostheses and incontinence, aiming to improve treatment options and outcomes for patients.

Research Articles:

Dr. Duygu Kirkik has contributed to several research articles focusing on various aspects of immunology and medical genetics. One of her notable works includes a study on the immune response and therapeutic vaccination against Helicobacter pylori, published in the Brazilian Archives of Biology and Technology in 2023. Another research article co-authored by Dr. Kirkik investigates the effects of MIR-219-1 gene variants on the development of disease in nonsmall cell lung cancer patients, published in African Health Sciences in 2022. Additionally, Dr. Kirkik has contributed to a study on adoptive T-cell therapies to overcome T cell-dependent immune dysregulations in COVID-19, highlighting her interest and expertise in immunology and infectious diseases.

Awards:

Dr. Duygu Kirkik has achieved significant milestones in her academic and professional career. She was awarded the YÖK/100/2000 PhD Scholarship in Translational Medicine at the University of Health Sciences, Department of Medical Biology, where she pursued her doctoral studies from 2018 to 2022. In 2017, she secured the Third Prize in the Yıldız Teknik TTO & Çalık Holding First Job Entrepreneurship Competition. Dr. Kirkik also obtained a Successful Internship Certificate from Oxford University, Department of Medical Genetics, in 2014. Her academic journey was further enriched by receiving an Erasmus Grant from the European Commission through the Turkish National Agency for the United Kingdom in 2014. Additionally, she was a recipient of the TÜBİTAK 1003 Project Assistant Scholarship and the Fatih University BAP – Project Assistant Scholarship from 2013 to 2015. In 2012, Dr. Kirkik was awarded an Erasmus Grant from the European Commission through the Turkish National Agency for the Czech Republic. These accomplishments reflect her dedication to academic excellence and professional development.

Publications:

Polymorphisms in Toll-like receptors 1, 2, 5, and 10 are associated with predisposition to Helicobacter pylori infection
- Authors: SK Tas, D Kirkik, A Tanoglu, R Kahraman, K Ozturk, MF Esen, …
- Citations: 12
- Year: 2020
Role of ACE2 gene expression in Renin Angiotensin System and its importance in Covid-19: In Silico Approach
- Authors: SK Tas, D Kirkik, ME Isik, N Kalkanli, AS Uzunoglu, MS Uzunoglu, …
- Citations: 6
- Year: 2020
Determination of B-and T-cell epitopes for Helicobacter pylori cagPAI: An in silico approach
- Authors: SK Taş, D Kırkık, K Öztürk, A Tanoğlu
- Citations: 5
- Year: 2020
Biomaterials used in dental applications
- Authors: D KIRKIK, B Karabulut, K Öztürk, SK TAŞ
- Citations: 4
- Year: 2019
The important role of TMPRSS2 Gene in covid-19 and prostate cancer: in silico approach
- Authors: A Kalkanli, D Kirkik, E Bostanci, SK Tas
- Citations: 3
- Year: 2021
Investigation of the effects of mir-219-1 gene variants on the development of disease in non-small cell lung cancer patients
- Authors: SK Tas, E Coskunpinar, P Yildiz, M Bayraktaroğlu, T Kose, D Altunkanat, …
- Citations: 1
- Year: 2022
Evaluation of in silico analysis of the CTLA-4 gene in autoimmune thyroid diseases
- Authors: D KIRKIK, SK TAŞ, E ÇAĞILTAY, N KALKANLİ
- Citations: 1
- Year: 2020
Genetic insights into bladder cancer: the impact of SIRT1 gene polymorphism
- Authors: E Bostanci, D Kirkik, S Kalkanli Tas, U Uyeturk
- Citations: Not provided
- Year: 2024
Unraveling the blood microbiome: novel insights into inflammasome responses in Crohn’s disease
- Authors: D Kirkik, SK Tas, A Tanoglu
- Citations: Not provided
- Year: 2024
The Integration of RNA Sequencing and Proteomics in Early Detection and Personalized Treatment in Cancer Research
- Authors: D KIRKIK, SK TAS
- Citations: Not provided
- Year: 2023

Dr. Prashant Regmi | Clinical Biochemistry | Best Researcher Award

Lecturer at Clinical Biochemistry, Charles Darwin University, Australia

👨‍🎓He remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 He successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

PhD in Medicine from The University of Adelaide, Australia (2017-2021) with a research focus on the Impact of Time-restricted feeding on glucose metabolism and metabolic health. M.Sc. in Clinical Biochemistry from the Institute of Medicine, Tribhuvan University, Nepal (2009-2012) with a Gold Medal. B.Sc. in Medical Laboratory Technology from BP Koirala Institute of Health Sciences, Nepal (2005-2008).

Experience:

Since March 2023: Lecturer-Biomedical Science at the Faculty of Health, Charles Darwin University, Australia. Responsibilities include teaching medical biochemistry, clinical biochemistry, and diagnostic haematology at both the bachelor’s and master’s levels, as well as conducting research projects and supervising research students. From October 2021 to March 2023: Clinical Trial Associate at Avance Clinical Research, Adelaide, Australia. Responsibilities included coordinating and managing clinical trials in Australia and New Zealand. From July 2013 to March 2017: Lecturer and Clinical Biochemist at Nepal Medical College and Teaching Hospital, Kathmandu, Nepal. Responsibilities included… (please provide the specific responsibilities for this position).

Prashant Regmi ‘s citation metrics and indices from Google Scholar are as follows:

Cited by: All: 859, Since 2018: 682
Citations: 859 (All), 682 (Since 2018)
h-index: 9 (All), 8 (Since 2018)
i10-index: 9 (All), 7 (Since 2018)

These metrics showcase the impact of Regmi ‘s work within the academic community, demonstrating the number of citations his publications have received and the influence of his research output.

Skills:

Dr. Prashant Regmi is highly proficient in various aspects of biochemistry, including real-time PCR, clinical chemistry, Western blotting, problem-based and case-based learning, metabolism, immunohistochemistry, pathophysiology, ELISA, cell and molecular biology, immunofluorescence, blood banking, endocrinology, flurometry/spectrophotometry, quality control of laboratory procedures, diagnostic biomarker interpretation, laboratory techniques, metabolic disease research, project management, clinical trials, curriculum design, as well as supervision/mentorship, student evaluation, education pedagogy, and scientific & succinct writing.

Award and Honors:

Nepal Vidhyabhusan ‘KHA’ (Nepal Education Medal ‘B’) from President Dr. Ram Baran Yadav of Nepal.
Society of Endocrinology Journal Award 2022, Harrogate, UK.
Top 12 highest scoring research, the Obesity week 2019, Las Vegas, USA.
Australian Permanent Residency as a Global Talent in Medical Science (Australian Government).

Memberships:

Dr. Prashant Regmi is a professional member (MAIMS) of the Australian Institute of Medical Scientists and a founder member of the Nepalese Association for Clinical Chemistry. They are also a professional member of the Nepal Health Professional Council (NHPC), specializing in Medical Biochemistry (registration No: 71) since October 29, 2015, and Diagnostic Health Laboratory (registration No: A-361) since May 10, 2009. Dr. Prashant Regmi served as the Treasurer of the Nepalese Association for Clinical Chemistry from January 2015 to February 2017 and has been a lifetime member of the Nepal Association for Medical Laboratory Science (NAMLS) since July 2009.

Publications:

Time‐Restricted Feeding Improves Glucose Tolerance in Men at Risk for Type 2 Diabetes: A Randomized Crossover Trial

Published in Energy in 2019 with 339 citations.

Association between glycaemic control and serum lipid profile in type 2 diabetic patients: Glycated haemoglobin as a dual biomarker.

Published in Energy in 2011 with 235 citations.

Published in Energy in 2020 with 106 citations.

Published in Energy in 2009 with 40 citations.

Published in Energy in 2021 with 33 citations.

Published in Energy in 2012 with 24 citations.

Published in Energy in 2017 with 17 citations.